Home ›
Trademark Categories ›
Pharmaceuticals ›
2012 ›
MA ›
MARKLAS
Trademark search for:
MARKLAS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2012-03-07 — Application filed
2012-04-14 — Sn assigned for sect 66a appl from ib
2012-04-16 — Application filed
2012-04-20 — Application filed
2012-06-16 — Final disposition recorded
2012-06-16 — Assigned to examiner
2012-06-17 — Office action issued
2012-06-18 — Office action issued
2012-06-18 — Office action issued
2012-07-07 — Office action issued
2012-08-01 — Office action issued
2012-08-03 — Assigned to lie
2012-08-16 — Teas/email correspondence entered
2012-08-16 — Correspondence received in law office
2012-08-17 — Approved for pub - principal register
2012-08-23 — Law office publication review completed
2012-09-05 — Notification of possible opposition sent to ib
2012-09-05 — Notification of notice of publication e-mailed
2012-09-05 — Notice of start of opposition period created, to be sent to ib
2012-09-25 — Published for opposition
2012-09-25 — Official gazette publication confirmation e-mailed
2012-10-25 — Notification processed by ib
2012-12-11 — Registered-principal register
2013-03-11 — Final disposition recorded
2013-03-16 — Final disposition recorded
2013-03-16 — Final disposition recorded
2013-04-16 — Final disposition recorded
2013-05-30 — Teas change of correspondence received
2017-12-11 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2018-03-06 — Attorney/dom.rep.revoked and/or appointed
2018-03-06 — Teas revoke/app/change addr of atty/dom rep received
2018-06-15 — New representative at ib received
2019-07-12 — Cancelled section 71
2020-03-12 — Total invalidation of reg ext protection created
2020-05-26 — Total invalidation of reg ext protection sent to ib
2020-05-26 — Invalidation processed
2020-06-19 — Total invalidation processed by the ib
2022-03-07 — Final status recorded
2022-10-01 — Death of international registration
2022-10-01 — Notification of effect of cancellation of intl reg e-mailed
Owner Information
Actelion Pharmaceuticals Ltd
CH
Actelion Pharmaceuticals Ltd
CH
Actelion Pharmaceuticals Ltd
CH
Correspondent
Cheryl Foytlin Johnson & Johnson ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK, NJ 08933 UNITED STATES
Filing Details
Filing Date:
2012-03-07
Status Date:
2022-03-07
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.